MapLight Therapeutics is the…
MapLight Therapeutics is the latest biotech to want a turn [...]
As both Novo Nordisk and Eli Lilly…
As both Novo Nordisk and Eli Lilly race to develop [...]
The FDA has approved Enhertu…
The FDA has approved Enhertu combined with Roche’s Perjeta as [...]
Aviceda Therapeutics has hit a…
Aviceda Therapeutics has hit a snag in its goal to [...]
The FDA has signed off on…
The FDA has signed off on Milestone Pharmaceuticals’ Cardamyst, a [...]
Fresh off a $153 million series E…
Fresh off a $153 million series E round, Arthrosi Therapeutics [...]
F.D.A. Approves Two New Drugs to Treat Gonorrhea
The sexually transmitted disease has become increasingly resistant to existing [...]
After three decades of no new…
After three decades of no new antibiotics for the treatment [...]
The CDC findings were released as…
The CDC findings were released as the FDA considers placing [...]
GSK’s depemokimab, a long-acting…
GSK’s depemokimab, a long-acting biologic that’s key to the British [...]